Aurora Cannabis (TSE:ACB) Stock Price Down 2.6% – Time to Sell?

Aurora Cannabis Inc. (TSE:ACB)’s stock price fell 2.6% during trading on Wednesday. The company traded as low as C$5.42 and last traded at C$5.56. 406,437 shares changed hands during trading, a decline of 1% from the average daily volume of 410,680 shares. The stock had previously closed at C$5.71.

Analyst Ratings Changes

Several brokerages have recently weighed in on ACB. Canaccord Genuity Group decreased their target price on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. ATB Cormark Capital Markets cut shares of Aurora Cannabis from an “outperform” rating to a “tender” rating and cut their price target for the stock from C$6.50 to C$5.60 in a research note on Wednesday, August 19th. TD decreased their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Finally, BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a research note on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Aurora Cannabis has a consensus rating of “Moderate Buy” and an average price target of C$6.20.

Aurora Cannabis Stock Down 2.6%

The stock has a market capitalization of C$344.48 million, a price-to-earnings ratio of -2.87 and a beta of 0.42. The firm has a 50 day simple moving average of C$5.05 and a 200-day simple moving average of C$4.69. The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48.

Aurora Cannabis (TSE:ACB) last issued its earnings results on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The firm had revenue of C$67.55 million during the quarter. On average, sell-side analysts forecast that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.